Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating intra-anal nifedipine as an add-on to conservative therapy for reducing pain in chronic anal fissure has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (intra-anal formulation) (nifedipine)

Snippet

Sponsor: RDD Pharma Ltd | Conditions: Chronic Anal Fissure | Phase 2, Phase 3 | Status: COMPLETED